177Lu PSMA Vision - Search Videos

Beyond 177Lu PSMA: Alpha and Combination Treatments – Dr Partha Choudhary | BNMS Spring Meeting 2025 | Aruni Ghose

Beyond 177Lu PSMA: Alpha and Combination Treatments – Dr Partha Choudhary | BNMS Spring Meeting 2025 | Aruni Ghose

7.8K views4 months ago

PSMA and Recurring Prostate Cancer

PSMA and Recurring Prostate Cancer

WebMDLinda Rath

The VISION Study of 177Lu-PSMA-617 in mCRPC | OncLive

The VISION Study of 177Lu-PSMA-617 in mCRPC | OncLive

Treatment Sequencing in mCRPC: Evidence From VISION, TheraP, and Cabazitaxel Use After 177Lu-PSMA-617

Treatment Sequencing in mCRPC: Evidence From VISION, TheraP, and Cabazitaxel Use After 177Lu-PSMA-617

154 views11 months ago

VISION Trial: Novel PSMA-Targeted Radiotherapy Improves Outcomes in Metastatic Prostate Cancer

VISION Trial: Novel PSMA-Targeted Radiotherapy Improves Outcomes in Metastatic Prostate Cancer

ESMO 2025 Insights: Phase 3 PSMAddition Trial of [177Lu]Lu-PSMA-617 Combined With ADT ARPI for PSMA mHSPC

ESMO 2025 Insights: Phase 3 PSMAddition Trial of [177Lu]Lu-PSMA-617 Combined With ADT ARPI for PSMA mHSPC

144 views6 months ago

FDA Approval of 177Lu-PSMA-617 for Taxane-Naive mCRPC - Oliver Sartor

FDA Approval of 177Lu-PSMA-617 for Taxane-Naive mCRPC - Oliver Sartor

Use of PSMA PET Scans in Advanced Prostate Cancer | OncLive

ESMO 2025 Insights: 177Lu-PSMA-617 in mCRPC Shows Higher PSA Response and Fewer Toxicities Compared With Docetaxel

5 views5 months ago

ESMO 2025 Insights: 177Lu-PSMA-617 With ADT ARPI Improves rPFS in mHSPC - PSMAddition Study Outcomes

25 views5 months ago

PSMA-Targeted Radioligand Therapy in Advanced Prostate Cancer | OncLive

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treatment With 177Lu-PSMA-617 SoC & SoC Alone in Pts With mHSPC"

1.8K viewsJun 8, 2023

Lutetium-177 PSMA Therapy for Prostate Cancer (Pluvicto) - UChicago Medicine

uchicagomedicine.org

What is the Role of 177Lu-PSMA-617 in Metastatic CRPC? | OncLive

Dr. Morris on the Efficacy of 177Lu-PSMA-617 Plus Best SOC in mCRPC | OncLive

Dr. Tagawa on the Investigation of 225Ac-J591 and 177Lu-PSMA-I&T in mCRPC | OncLive

VISION Study | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

targetedonc.com

Evaluating the future of 177Lu-PSMA-617 combination therapies in mCRPC

18 views1 month ago

YouTubeVJOncology

177Lu-PSMA-617 after sipuleucel-T in mCRPC: PRECISION analysis

23 views2 months ago

YouTubeVJOncology

PRESERVE-006: Phase I trial of gotistobart and 177Lu-PSMA-617 in mCRPC

15 views1 month ago

YouTubeVJOncology

Lu-177 PSMA Therapy: Clinical Adoption & Future Landscape

11 views1 month ago

YouTubeDavid Capobianco

EP 35 A Ciência que Cura: De Médico a Paciente | Medical IsoTalks

247 views1 month ago

YouTubeMedical IsoTalks

전립선암 치료, 비용 때문에 망설였다면, 꼭 보세요! #shorts #전립선암 #전이성전립선암 #전립선암치료 #루테시움 #psma #암환자 #비뇨기과 #건강정보 #남성건강

709 views2 weeks ago

YouTube건전한 비뇨기과 김교수

New Study Shows High Efficacy and Patient Tolerance with 177Lu-PSMA-617 in Older Men with mCRPC | Diagnostic Imaging®

Could Pluvicto Be a First-Line Systemic Treatment for Patients with Oligometastatic Hormone-Sensitive PCa? | Diagnostic Imaging

diagnosticimaging.com

Detecting prostate cancer with PSMA PET

12.7K viewsDec 1, 2020

YouTubeUCLA Health

What is PSMA-PET Scan Radioactive Imaging?

25K viewsDec 1, 2020

YouTubeProstate Cancer Foundation

What is Lutetium 177? | Mercy Radiology

4K viewsFeb 17, 2020

YouTubeAllevia Radiology

Prostate Cancer Cure: How Does Nuclear Medicine Work?

7.5K viewsMay 4, 2021

YouTubeSociety of Nuclear Medicine and Molecular Ima…

Using Lutetium-177 Treatment For Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

9.9K viewsJun 9, 2020

YouTubeProstate Cancer Research Institute

See more